![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
欧洲植物疫苗市场预测至 2028 年 - COVID-19 影响和按疫苗类型(细菌疫苗、病毒疫苗、寄生虫疫苗等)、来源(烟草植物、玉米、马铃薯等)和应用进行的区域分析(流感、寨卡病毒、埃博拉病毒、家禽疾病等)
市场介绍
欧洲植物疫苗市场包括德国的综合市场、法国、英国和欧洲其他国家。由于老年人口增加、慢性病毒性疾病患病率增加以及该地区对新抗原开发的高需求等因素,欧洲将成为预测期内的第二大市场。此外,用于研究和开发的资金不断增加。未来几年的开发活动可能会在该地区增加更多机会。
可靠且及时的 COVID-19 检测是监测、预防、接触记录、感染控制以及 COVID-19 的临床管理。欧洲疾病预防和控制中心(ECDC)考虑到现有的公共卫生工具和检测能力,为欧盟提出了一项分析检测策略,其中包括关于病毒在人群中传播水平的具体指南。欧盟委员会健康保护委员会于 2020 年 9 月进行的一项调查调查了成员国使用快速抗原检测的活动。 15 个欧盟成员国对调查做出了回应,其中 5 个国家正在针对应对 COVID-19 大流行的某些方面使用快速抗原测试。 15个国家中有9个目前正在进行临床验证试验或试点,以评估快速抗原检测的临床/诊断效率和未来使用,还有2个成员国不考虑使用快速抗原检测。报告称,一些国家将这些检测作为其研究政策的一部分,以早期发现感染、追踪接触者和/或快速隔离以及对已发现的病例及其接触者进行隔离。其他国家明确使用快速抗原检测,以确保在 RT-PCR 金标准不可用或不够及时的偏远地区进行实验室检测。
市场概况和动态
工厂欧洲基于疫苗的市场预计将从2021年的3.064亿美元增长到2028年的7.0515亿美元;预计 2021 年至 2028 年复合年增长率为 12.6%。流感是由流感病毒引起的高度传染性呼吸道疾病。流感病毒的基因不断变化,极大地影响诱导免疫和疫苗配方。据世界卫生组织 (WHO) 称,当感染者咳嗽或打喷嚏时,含有病毒的飞沫(传染性飞沫)会传播到空气中,传播距离可达一米,从而感染附近吸入这些飞沫的人。女性、儿科医生、老年科医生、免疫力低下的慢性病患者以及医护人员都有感染流感的风险。结果,欧洲对疫苗的需求猛增。这些因素可能会在预测期内推动全球植物疫苗市场向前发展。
主要细分市场
欧洲植物疫苗市场按疫苗类型、来源、应用和国家细分。根据疫苗类型,欧洲植物疫苗市场分为细菌疫苗、病毒疫苗、寄生虫疫苗、植物源病毒样颗粒等。 2021年,细菌疫苗占据了最大的市场份额。根据来源,欧洲植物疫苗市场分为烟草植物、玉米、马铃薯等。 2021年,烟草植物疫苗占据了最大的市场份额。根据应用,欧洲植物疫苗市场分为流感、寨卡病毒、埃博拉病毒、家禽疾病、COVID-19等。 2021年,流感细分市场占据最大市场份额。根据国家/地区,欧洲植物疫苗市场分为法国、德国、意大利、西班牙、英国和欧洲其他地区。德国在 2021 年占据最大的市场份额。
主要来源和上市公司
准备本欧洲植物疫苗市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有英美烟草公司;创意生物实验室有限公司;叶表达系统有限公司;莱尼奥生物;流明生物科学公司;和 ZYUS Life Sciences Inc.
购买报告的理由
- 了解欧洲植物疫苗市场格局并确定最有潜力的细分市场可能会保证强劲的回报。
- 了解欧洲植物疫苗市场不断变化的竞争格局,保持领先地位。
- 通过确定最有可能销售的细分市场,有效规划欧洲植物疫苗市场的并购和合作交易。
- 帮助掌握知识通过对欧洲植物疫苗市场各个细分市场表现的敏锐和全面的分析来做出业务决策。
- 获取2021-2028年欧洲各个细分市场的市场收入预测地区。
欧洲植物疫苗市场细分
欧洲植物疫苗市场 - 按疫苗类型
- 细菌疫苗
- 病毒疫苗
- 寄生虫疫苗 span>
- 植物源性病毒样颗粒
- 其他
< span>欧洲植物疫苗市场 - 按来源
- 烟草植物
- 玉米
- 马铃薯
- < span>其他
欧洲植物疫苗市场 - 按应用
- 流感
- 寨卡病毒
- 埃博拉病毒
- COVID-19
- 家禽疾病
- 其他
欧洲植物疫苗市场 - 按国家/地区
- 法国
- 德国
- 意大利
- 西班牙
- 英国
- 欧洲其他地区
欧洲植物疫苗市场 - 公司简介
- 英美烟草公司
- Creative Biolabs , Inc.
- Leaf Expression Systems Ltd.
- LenioBio
- Lumen Bioscience, Inc.
- ZYUS Life Sciences Inc.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Plant-based Vaccines Market – By Vaccine Type
1.3.2 Europe Plant-based Vaccines Market – By Source
1.3.3 Europe Plant-based Vaccines Market – By Application
1.3.4 Europe Plant-based Vaccines Market – By Country
2. Europe Plant-based Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Plant-based Vaccines Market– Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Plant-based Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Significant Rise in Number of Research & Development (R&D) Activities in Plant-Based Vaccines
5.1.2 Infectious Diseases Getting Quite Prevalent
5.2 Market Restraints
5.2.1 Manufacturing Plant-Based Vaccines Facing Potential Risk of Contamination Including Environmental Risks
5.3 Market Opportunities
5.3.1 Production Surge in Plant-Based Vaccines
5.4 Future Trends
5.4.1 High Rise in Product Approvals
5.5 Impact Analysis
6. Plant-based Vaccines Market– Europe Analysis
6.1 Europe Plant-based Vaccines Market Revenue Forecast and Analysis
7. Europe Plant-Based Vaccines Market Analysis – By Vaccine Type
7.1 Overview
7.2 Europe Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
7.3 Bacterial Vaccines
7.3.1 Overview
7.3.2 Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.4 Viral Vaccines
7.4.1 Overview
7.4.2 Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.5 Parasite Vaccines
7.5.1 Overview
7.5.2 Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.6 Plant-derived Virus-like Particles (VLPs)
7.6.1 Overview
7.6.2 Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Plant-based Vaccines Market Analysis – By Source
8.1 Overview
8.2 Europe Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
8.3 Tobacco Plant
8.3.1 Overview
8.3.2 Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.4 Maize
8.4.1 Overview
8.4.2 Maize: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.5 Potato
8.5.1 Overview
8.5.2 Potato: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9. Europe Plant-based Vaccines Market Analysis– by Application
9.1 Overview
9.2 Europe Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
9.3 Influenza
9.3.1 Overview
9.3.2 Influenza: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.4 Zika Virus
9.4.1 Overview
9.4.2 Zika Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.5 Ebola Virus
9.5.1 Overview
9.5.2 Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.6 Poultry Disease
9.6.1 Overview
9.6.2 Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.7 Covid-19
9.7.1 Overview
9.7.2 COVID-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
10. Europe Plant-based Vaccines Market – Country Analysis
10.1 Overview
10.1.1 Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.2 Germany: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 Germany: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 Germany: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.1.1.2 France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.2 France: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3 France: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 France: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.1.1.3 UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.2 UK: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 UK: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4 UK: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.1.1.4 Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.2 Italy: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3 Italy: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.4 Italy: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.1.1.5 Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.1 Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.2 Spain: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3 Spain: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.4 Spain: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
10.1.1.6 Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.1 Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.2 Rest of Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3 Rest of Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.4 Rest of Europe: Plant-based Vaccines Market, By Application– Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic On Europe Plant-based Vaccines Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Plant-based Vaccines Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Plant-based Vaccines Market, 2019-2021
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 British American Tobacco p.l.c.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ICON GENETICS GMBH
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CREATIVE BIOLABS, INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 LENIOBIO
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 LEAF EXPRESSION SYSTEMS LTD.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 ZYUS LIFE SCIENCES INC.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 4. France: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 5. France: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 6. France: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 7. UK: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UK: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 10. Italy: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Italy: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 12. Italy: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 13. Spain: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Spain: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 16. Rest of Europe: Plant-based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Europe: Plant-based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Europe: Plant-based Vaccines Market, By Application – Revenue and Forecast to 2028 (USD Million).
Table 19. Recent organic developments in the Plant-based Vaccines Market
Table 20. Glossary of Terms, Europe Plant-based vaccines devices market
LIST OF FIGURES
Figure 1. Europe Plant-based Vaccines Market Segmentation
Figure 2. Europe Plant-based Vaccines Market Segmentation, By Country
Figure 3. Europe Plant-based Vaccines Market Overview
Figure 4. Bacterial Vaccines Held the Largest Share of the Vaccine Type Segment in Europe Plant-based Vaccines Market
Figure 5. Germany to Show Significant Growth during Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Europe Plant-Based Vaccines Market Impact Analysis of Driver and Restraints
Figure 8. Europe Plant-based Vaccines Market– Revenue Forecast and Analysis – 2019- 2028
Figure 9. Europe Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
Figure 10. Europe Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Europe Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Europe Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Europe Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
Figure 16. Europe Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe Maize: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Europe Potato: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Europe Others: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Europe Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
Figure 21. Europe Influenza: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Europe Zika Virus: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Europe Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 24. Europe Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 25. Europe COVID-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 26. Europe Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 27. Europe: Plant-based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. Europe: Plant-based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 29. Germany: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. France: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. UK: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Italy: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Spain: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of Europe: Plant-based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic In European Country Markets
Figure 36. Growth Strategies in the Plant-based Vaccines Market, 2019-2021- British American Tobacco p.l.c.
- Creative Biolabs, Inc.
- Leaf Expression Systems Ltd.
- LenioBio
- Lumen Bioscience, Inc.
- ZYUS Life Sciences Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe plant-based vaccines market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe plant-based vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the plant-based vaccines market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution